U-91356A

Known as: U 91356A, U91356A 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Dopaminergic (DA) agonist-induced yawning in rats seems to be mediated by DA D3 receptors, and low doses of several DA agonists… (More)
Is this relevant?
2001
2001
We have shown previously that prenatal exposure of rats to 0.5 mg/kg/day of methylmercury (MeHg) produces gender-dependent… (More)
Is this relevant?
2000
2000
Three separate groups of rats were trained to discriminate the putative D3 dopamine receptor agonists (+/-)-7… (More)
Is this relevant?
1997
1997
The effect of chronic treatment with the D2 dopamine agonist U91356A or L-DOPA therapy on the regulation of preproenkephalin (PPE… (More)
Is this relevant?
1997
1997
This study was designed to validate an in vivo measurement of the functional sensitivity of basal ganglia neuronal circuits… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1997
1997
The effect of a chronic D2 dopamine receptor agonist (U91356A) treatment on dopamine receptor gene expression in the brain of 1… (More)
Is this relevant?
1995
1995
Dopamine D1 and D2 receptors as well as the GABA/benzodiazepine receptor complex in the striatum and the globus pallidus… (More)
Is this relevant?
1995
1995
Several dopamine agonists (apomorphine, quinpirole, 7-OH-DPAT, and U-91356A) suppressed locomotor activities of rats exploring a… (More)
  • table 1
  • table 3
  • table 2
  • figure 2
Is this relevant?